RUA Rua Bioscience Limited
—Mkt Cap: —P/E: —Today
Rua Bioscience Limited engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally. It offers cannabis-derived medicines. The company is also involved in plant research, g…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap—
Enterprise Value6.39M USD
Revenue (TTM)1.57M USD
Gross Profit-66.26K USD
Net Income (TTM)-7.68M USD
Revenue/Share0.01 NZD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryNZ
SectorHealthcare
IndustryDrug Manufacturers - General
ISINNZRUAE0004S1
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-4.16
EV/Revenue4.06
P/S3.75
P/B2.31
EPS (TTM)-0.01
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin-137.83%
Oper. Margin-110.78%
EBITDA Margin-97.54%
Profit Margin-15982.33%
ROE-202.74%
ROA-177.25%
Growth
Revenue Growth44.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.66M USD
CapEx (TTM)677 USD
FCF Margin-71.27%
FCF Yield—
Net Debt684.23K USD
Net Debt/EBITDA-0.45
Balance Sheet
Debt/Equity0.02
Current Ratio1.08
Quick Ratio0.37
Book Value/Sh0.01 NZD
Cash/Share0.0020 NZD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 NZD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.351.56M
Float219.15M
Insiders45.01%
Institutions5.12%
Technical
SMA 500.0325 NZD
SMA 2000.0324 NZD
Beta0.58
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)156.87K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—